Understanding the Potential of Epicatechin (December 2015)
by: Parent Project Muscular Dystrophy
Understanding the Potential of Epicatechin (December 2015)
On December 16, 2015, PPMD Founding President and CEO, Pat Furlong interviewed Dr. George Schreiner, President and CSO of Cardero Therapeutics, Inc. to discuss the potential benefits of epicatechin to people with Duchenne. It was a fascinating conversation about an all-natural therapy that could benefit the entire Duchenne population, regardless of age or gene mutation.
by: Parent Project Muscular Dystrophy
